CANTARA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 6.104
EU - Europa 5.896
AS - Asia 3.084
SA - Sud America 546
AF - Africa 205
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.853
Nazione #
US - Stati Uniti d'America 6.003
RU - Federazione Russa 1.341
GB - Regno Unito 1.139
IT - Italia 1.056
SG - Singapore 1.039
CN - Cina 924
IE - Irlanda 733
BR - Brasile 442
SE - Svezia 377
VN - Vietnam 327
DE - Germania 289
FR - Francia 280
HK - Hong Kong 236
UA - Ucraina 229
KR - Corea 173
FI - Finlandia 167
IN - India 123
ZA - Sudafrica 118
NL - Olanda 62
ES - Italia 50
CA - Canada 49
TR - Turchia 48
AR - Argentina 43
PL - Polonia 42
JP - Giappone 37
BD - Bangladesh 34
MX - Messico 28
IQ - Iraq 24
AT - Austria 22
BE - Belgio 22
IR - Iran 22
CI - Costa d'Avorio 21
AU - Australia 14
MA - Marocco 14
CH - Svizzera 13
EG - Egitto 13
CL - Cile 12
CZ - Repubblica Ceca 12
EC - Ecuador 11
SA - Arabia Saudita 11
CO - Colombia 10
JO - Giordania 10
LT - Lituania 10
PK - Pakistan 10
UZ - Uzbekistan 10
VE - Venezuela 10
GR - Grecia 9
JM - Giamaica 9
KE - Kenya 9
DZ - Algeria 8
ID - Indonesia 8
NG - Nigeria 8
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
LV - Lettonia 6
PH - Filippine 6
RO - Romania 6
BO - Bolivia 4
CR - Costa Rica 4
IL - Israele 4
KZ - Kazakistan 4
NP - Nepal 4
BB - Barbados 3
BG - Bulgaria 3
EE - Estonia 3
ET - Etiopia 3
EU - Europa 3
LU - Lussemburgo 3
NO - Norvegia 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IM - Isola di Man 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
BY - Bielorussia 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
MT - Malta 1
Totale 15.844
Città #
Southend 996
Dallas 811
Dublin 720
Fairfield 600
Singapore 570
Ashburn 460
Moscow 401
Santa Clara 358
Chandler 346
Woodbridge 236
Seattle 224
Hong Kong 221
Hefei 219
Wilmington 216
San Jose 214
Beijing 206
Houston 187
Jacksonville 183
Cambridge 176
Siena 171
Seoul 169
Florence 165
Ann Arbor 158
The Dalles 118
Los Angeles 113
Ho Chi Minh City 107
Johannesburg 107
Munich 97
Council Bluffs 95
Milan 91
Princeton 90
Lauterbourg 89
New York 87
Helsinki 84
Hanoi 67
Nanjing 53
São Paulo 51
Shanghai 45
Rome 41
Buffalo 39
San Diego 38
Poggiomarino 37
Chicago 35
Boardman 34
Potenza Picena 33
Bengaluru 32
Orem 32
Turku 32
Warsaw 32
London 30
Redondo Beach 30
San Mateo 30
Lappeenranta 28
Montreal 27
Tokyo 27
Frankfurt am Main 26
Chennai 25
Columbus 24
Dearborn 24
Abidjan 21
Málaga 21
Brussels 20
Lancaster 20
Brooklyn 18
Stockholm 18
Tianjin 18
Izmir 16
Nanchang 16
Amsterdam 15
Fremont 15
Redwood City 15
Belo Horizonte 14
Haiphong 14
Manchester 14
Nuremberg 14
Portsmouth 14
Atlanta 13
Da Nang 13
Denver 13
Düsseldorf 13
Guangzhou 13
Kunming 13
Ravenna 13
Rio de Janeiro 13
Shenyang 13
Dong Ket 12
Vienna 12
Zurich 12
Clifton 11
Curitiba 11
Jiaxing 11
Poplar 11
Turin 11
Boston 10
Brasília 10
Cairo 10
Hebei 10
San Francisco 10
Washington 10
Amman 9
Totale 10.517
Nome #
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 368
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 339
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 312
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 311
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 299
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 294
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 290
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 289
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 275
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 270
Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies 268
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 261
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 259
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 257
Clinical significance of type 2 iodothyronine deiodinase polymorphism 255
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 246
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 236
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 235
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 232
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 231
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 227
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 217
Gene-related alterations in four male patients with elevated serum gonadotrophins levels 216
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 214
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 213
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 213
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 212
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 212
BROX haploinsufficiency in familial nonmedullary thyroid cancer 199
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 199
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 196
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 191
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 188
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 186
Mitigation of UV-B Radiation Stress in Tobacco Pollen by Expression of the Tardigrade Damage Suppressor Protein (Dsup) 186
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 184
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 182
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 182
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 180
Proteomics Reveals How the Tardigrade Damage Suppressor Protein Teaches Transfected Human Cells to Survive UV-C Stress 179
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 179
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 178
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 177
miRNA Targets: From Prediction Tools to Experimental Validation 177
Follow-up after bariatric surgery: is it time to tailor it? Analysis of early predictive factors of 3-year weight loss predictors of unsuccess in bariatric patients 177
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 176
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 176
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 174
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics 172
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 172
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 171
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress 169
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 166
Telomeres and thyroid cancer 166
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 164
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 163
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 161
Silent thyroiditis following vaccination against COVID-19: report of two cases 160
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 159
Familial non-medullary thyroid cancer: a critical review 156
Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight 153
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium 152
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 152
Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer 147
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 143
HLA class I expression on human platelets is highly variable and correlates with distinct allele group frequencies 142
Opposite effects of beta amyloid on endothelial cell survival: role of fibroblast growth factor-2 (FGF-2) 142
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 142
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer 137
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 134
Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery 133
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade 132
TAT-BH4 counteracts A beta toxicity on capillary endothelium 128
null 126
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 121
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 120
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value 119
What's Wrong in a Jump? Prediction and Validation of Splice Site Variants 115
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology 111
Vemurafenib may overcome TNF-related apoptosis-inducing ligand (TRAIL) resistance in anaplastic thyroid cancer cells 106
PAPPA expression in indeterminate thyroid nodules as screening test to select patients for molecular testing 104
The impact of CPT1B rs470117, LEPR rs1137101 and BDNF rs6265 polymorphisms on the risk of developing obesity in an Italian population 91
Telomerase and the endocrine system. 76
Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update 70
Expression of the ring ligase PRAJA2 in thyroid cancer 66
null 60
Sex hormone profiles in patients with Torsades de Pointes ventricular tachycardia 57
null 36
Totale 16.111
Categoria #
all - tutte 50.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021289 0 0 0 0 0 0 0 0 0 138 72 79
2021/2022866 67 96 59 86 49 43 36 35 39 88 115 153
2022/20231.302 71 151 151 171 101 259 45 81 141 42 43 46
2023/20241.346 45 43 102 72 90 278 441 66 23 26 48 112
2024/20253.018 87 113 344 271 351 203 89 163 307 162 304 624
2025/20265.771 500 854 640 801 1.188 253 749 254 248 284 0 0
Totale 16.111